`
`In Re:
`
`US. Patent of Lane et al,
`
`Proceeding No.:
`
`IPR2018-00507
`
`Patent No.:
`
`8,410,131
`
`Application N0.:
`
`10;“463520
`
`For:
`
`CANCER TREATMENT
`
`PATENT OWNER’S POWER OF ATTORNEY IN AN INTER PARTES REVIEW
`
`Patent Owner Novartis Pharmaceuticals Corporation (“Novartis”) hereby appoints
`
`Nicholas N. Kallas (Reg. No. 31,530) and Laura K. Fishwick (Reg. No. 69,907) as its attorneys
`
`to prosecute the aforementioned proceeding and to transact all business in the United Patent and
`
`Trademark Office connected therewith.
`
`Please address all correspondence as follows:
`
`Nicholas N. Kallas
`
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`
`New York, NY 10] 04-3 800
`
`Telephone: (212) 218-2100
`Facsimile: (212) 218-2200
`nkallas@fchs.com
`
`Dated: February L 018
`J /
`DatediFe? uary _L,2018
`,
`r,
`/
`.- //
`(/§:;:...-’-/'gi/"N/a/
`
`" I
`f
`f:
`c'_.—v
`‘tg‘a/fif? ./'
`Peter]. Waibel ‘"
`
`
`Novartis Pharmaceuticals Corporation
`One Health Plaza
`
`aceuticals Corporation
`'-
`-
`One Health Plaza
`
`East Hanover, NJ 03936-1080
`
`East Hanover, NJ 0?936-1080
`
`Witnessed by;
`Witnessed by? _,
`r
`.
`f
`A"
`'" \ .
`C .‘V" i L-
`.
`KL)
`t
`'fo
`L
`,.;\.
`
`Signature
`Signature
`_,"
`"9")
`/
`L
`.l
`\_./
`h owl (3
`[REL-(h If]
`{‘3 {\u- (i
`C i/‘H; LU“) If]
`
`(
`
`.
`
`Printed name
`
`Printed name
`
`_
`
`